-
+4 +1
COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst
Some health companies' quarterly earnings were boosted by COVID-19 products in the past few years, and most are starting to see a shift away from pandemic profits for 2023. Wells Fargo analyst Mohit Bansal said as much about three companies reporting earnings this week: "COVID is pretty much out of the models. Pfizer (PFE) is probably the only one in our coverage where it is still a significant part of it because it was their biggest business last year."
-
+18 +1
A new weight loss drug could become the best-selling drug of all time. Who can afford it?
An Eli Lilly drug if approved for weight loss could become the best-selling drug of all time, but concerns are mounting about who will actually be able to afford it. Experts are confident that the drug, called tirzepatide, will be granted approval by the Food and Drug Administration sometime next year. If that’s the case, it would join two other popular — and expensive — recently approved weight loss drugs on the market, Wegovy and Saxenda, both from the drugmaker Novo Nordisk.
-
+16 +1
Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation
Democrats have sent the legislative text of a sweeping proposal for drug price controls to the U.S. Senate parliamentarian, who may report on Monday whether the provisions qualify for the budget reconciliation process that allows lawmakers to evade a filibuster and pass a bill with a simple majority.
-
+17 +1
FDA to review first ever over-the-counter birth control pill
Perrigo Company (PRGO.N) said on Monday its unit HRA Pharma has asked the U.S. Food and Drug Administration (FDA) to approve a daily birth control pill for over-the-counter (OTC) sale, the first such request for this type of contraception. The application from the HRA comes on the back of the U.S. Supreme Court's decision in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide.
-
+15 +1
Mark Cuban aims to lower prescription drug prices with online pharmacy
People searching for cheaper alternatives to high priced prescription drugs have a new and perhaps unexpected option. It's an online pharmacy founded by Mark Cuban, a billionaire businessman, Shark Tank star and owner of the Dallas Mavericks. His new direct-to-consumer company, Cost Plus Drugs, offers more than 100 generic medications at discounted prices. He joins Geoff Bennett to discuss.
-
+12 +1
Diabetes drug helps patients lose never-before-seen amounts of weight, study shows
A drug approved to treat Type 2 diabetes is extremely effective at reducing obesity, according to a new study. The drug, called tirzepatide, works on two naturally occurring hormones that help control blood sugar and are involved in sending fullness signals from the gut to the brain.
-
+16 +1
Pfizer will not sell drugs for profit in poor nations
US pharmaceutical firm Pfizer said it would sell its patented drugs at cost to 45 low-income countries.
-
+32 +1
Putting Big Bad Pharma Back on Trial in the COVID-19 Era
After graduating from Columbia University with a chemical engineering degree, my grandfather went on to work for Pfizer for almost two decades, culminating his career as the company’s Global Director of New Products. I was rather proud of this fact growing up — it felt as if this father figure, who raised me for several years during my childhood, had somehow played a role in saving lives.
-
+18 +1
Covid-19: Pfizer to allow developing nations to make its treatment pill
US drug company Pfizer has penned a deal to allow its experimental Covid-19 treatment pill to be made and sold in 95 developing nations. The deal with the UN-backed Medicines Patent Pool not-for-profit could make the treatment available to 53% of the world's population. But it excludes several countries that have had large Covid-19 outbreaks, including Brazil.
-
+20 +1
New Pfizer antiviral and ivermectin, a pharmacodynamic analysis
-
+4 +1
Analysis: Large pharma companies do little new drug innovation
Among their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.
-
+17 +1
New treatment destroys head and neck cancer tumours in trial
A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered. In a landmark trial, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival”, according to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS foundation trust.
-
+11 +1
Gut bacteria may reduce drug effectiveness suggests study
Common medications can accumulate in gut bacteria, a new study has found, altering bacterial function and potentially reducing the effectiveness of the drug.
-
+4 +1
Can blood from young people slow aging? Silicon Valley has bet billions it will
The Spanish firm Grifols helped set off a kerfuffle last year when it, along with other firms, offered nearly double the going price for blood donations for a COVID-19 treatment trial. Brigham Young University in Idaho had to threaten some enterprising students with suspension to keep them from intentionally trying to contract COVID-19. The trial failed, however, and now the Barcelona-based firm is hoping to extract something far more valuable from the plasma of young volunteers: a set of microscopic molecules that could reverse the process of aging itself.
-
+1 +1
Top Ways To Cut The Costs On Your Doctor Visits - AtoAllinks
If you are like the majority of Australians, you are overpaying for health care. Healthcare bills can be costly even with medical insurance. The sum of cash you pay on...
-
+15 +1
Magic shrooms: UAB studies benefits for addiction, pain
Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the active ingredient in hallucinogenic mushrooms.
-
+22 +1
Anti-Vaccine Activists Use A Federal Database To Spread Fear About COVID Vaccines
The largest U.S. database for detecting events that might be vaccine side effects is being used by activists to spread disinformation about COVID-19 vaccines. Known as the Vaccine Adverse Event Reporting System, or VAERS, the database includes hundreds of thousands of reports of health events that occurred minutes, hours or days after vaccination. Many of the reported events are coincidental — things that happen by chance, not caused by the shot. But when millions of people are vaccinated within a short period, the total number of these reported events can look big.
-
+19 +1
Amazon Wants to Eat Health Care Next
The tech giant may be opening its own pharmacies, and Google wants to mine patient data. The goal is not to fix a broken system but to exploit it. A few years ago, attending a tech conference that catered to an industry-friendly audience, I listened as a venture capitalist praised the upcoming possibilities for growth in the U.S. health care market.
-
+13 +1
Katie Porter PRESSES pharma CEO on industry's lies
Big pharma maintains drugs prices are massive because of the cost of drug R&D.
1 comments by kxh -
+15 +1
Paracetamol may be no better than a placebo in many cases
A review of paracetamol for 44 common pain conditions found no strong evidence to support its use in many instances. Paracetamol is also known as acetaminophen, Panadol, Tylenol.
Submit a link
Start a discussion